INTRODUCTION
Aldehyde dehydrogenase (ALDH) enzymes regulate retinoic acid biosynthesis, the clearance of toxic byproducts of reactive oxygen species (ROS) as well as other processes relevant to stem cell regulation. A large family of genes (20 in mice) encode ALDHs that oxidize of a variety of endogenous and exogenous aldehydes. The retinaldehyde dehydrogenase (RALDH) subfamily of ALDHs comprising Aldh1a1, Aldh1a2, Aldh1a3, and Aldh8a1 regulate development by catalyzing retinoic acid biosynthesis [1] [2] [3] . Other ALDHs can metabolize a wide range of aldehydes including the active derivative of cyclophosphamide (CY) [4] [5] [6] [7] , and lipid byproducts of ROS 8, 9 .
A variety of stem cells have been isolated based on their unusually high levels of ALDH activity. Levels of ALDH activity in cells can be inferred using Bodipy-aminoacetaldehyde (more commonly known by its commercial name Aldefluor), a fluorogenic ALDH substrate that can be taken up by live cells and measured by flow-cytometry 10 . Human hematopoietic stem cells (HSCs) are enriched among cells with high levels of ALDH activity 11, 12 . Mouse HSCs have also been isolated by the selection of cells with high levels of ALDH activity 13, 14 , though the utility of
Aldefluor for the isolation of mouse HSCs is controversial as another study has reported mouse HSCs do not exhibit high levels of Aldefluor staining 12 . Aldefluor staining has also been reported to enrich leukemic stem cells from some patients 15 , human breast epithelial stem cells and breast cancer stem cells 16 , and mouse neural stem cells 17 . Indeed, it has been proposed that high ALDH activity might be a general marker for normal and malignant stem cells 16 .
The high levels of ALDH activity in stem cells have been ascribed to Aldh1a1
expression. Immunohistochemistry performed on normal human breast epithelium and breast cancer found that antibody staining for Aldh1a1 correlated with Aldefluor activity 16 . Gene expression profiling of human 18 and mouse HSCs 19, 20 has revealed that Aldh1a1 is expressed at higher levels in HSCs as compared to other hematopoietic cells. Human hematopoietic progenitors expand in number and delay differentiation in culture after treatment with a chemical
For personal use only. on April 14, 2017. by guest www.bloodjournal.org From inhibitor of ALDHs, diethylaminobenzaldehyde (DEAB). This has been suggested to reflect a role for Aldh1a1 in the regulation of HSC differentiation 21 . Over-expression of Aldh1a1 in hematopoietic cells confers cyclophosphamide resistance 6 . As a result of these studies it has been suggested that Aldh1a1 may be an important regulator of stem cell function and the main determinant of ALDH activity (Aldefluor staining) in stem cells. Nonetheless, other ALDHs are also expressed in stem cells 19, 20, 22 and the role of individual ALDHs in the regulation of stem cell function and ALDH activity has never been tested.
We have found that Aldh1a1 expression is elevated in mouse HSCs and that expression increases dramatically with age. To test whether Aldh1a1 is required for stem cell function we examined Aldh1a1-deficient mice. Aldh1a1 deficient mice were constructed by targeted deletion of exon 11, which encodes the substrate binding and tetramerization domains critical for all known Aldh1a1 functions 23 . This mutation eliminates detectable Aldh1a1 protein expression and dramatically reduces retinoic acid biosynthesis in the liver 23 . Mating Aldh1a1-deficient mice with mice that are deficient for Aldh1a2 and Aldh1a3 completely eliminates all retinoic acid synthesis in the E10.5 dorsal retina, demonstrating that the mutant Aldh1a1 allele has a complete loss of function with respect to retinoic acid biosynthesis 24 . Nonetheless, the Aldh1a1-deficient mice are born in normal numbers, are fertile, and have an apparently normal lifespan 23 .
We have examined hematopoiesis, HSC function, and neural stem cell function in young and old adult Aldh1a1-deficient mice. As expected, Aldh1a1 non-cell-autonomously regulated the sensitivity of hematopoietic progenitors to cyclophosphamide. However, we were unable to detect any hematopoietic or neural stem cell defects in Aldh1a1-deficient mice. Aldh1a1 deficiency also did not affect Aldefluor staining of HSCs, and mouse HSCs could not be distinguished from other bone marrow cells based on Aldefluor staining. Aldh1a1 is therefore not a major determinant of ALDH activity in mouse HSCs, is dispensable for hematopoietic and neural stem cell function, and does not affect the maintenance of these cells during aging.
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MATERIALS AND METHODS

Mice and reagents
All mice used in this study were housed in the Unit for Laboratory Animal Medicine at the University of Michigan and all procedures were approved by the University Committee for the Use and Care of Animals . Aldh1a1 deficient mice 23 were backcrossed to C57BL/Ka-CD45.2:Thy-1.1 mice for four to eight generations before being studied. In reconstitution experiments, C57BL/Ka-CD45.2:Thy-1.2 mice aged at least 8 weeks were used as recipients.
Aldefluor was purchased from StemCell Technologies (Vancouver, Canada). Mobilization was induced by intraperitoneal injection of 200mg/kg cyclophosphamide (Bristol-Myers Squibb, New York, NY) followed by four daily injections of 250 μg/kg human G-CSF (Amgen, Thousand
Oaks, CA) as described 25 . For experiments in which mice were treated weekly with 5-fluorouracil (American Pharmaceutical Partners Inc., Schaumburg, IL), a dose of 150mg/kg was used as described 26 . Medium components were purchased from Gibco-Invitrogen (Carlsbad, CA) unless otherwise noted. Statistical significance was assessed using the homoscedastic Student's t-Test (P<0.05).
Flow-cytometry
HSCs were analyzed and isolated as previously described 20 . Bone marrow cells were flushed from the tibia and femurs using a 25 gauge syringe (Becton-Dickson, Franklin Lakes, NJ) into Hank's Buffered Salt Solution (without calcium or magnesium) plus 2% bovine serum.
Single cell suspensions were generated by trituration and passage through a 45 μm nylon filter (Sefar America, Kansas City, MO 
Quantitative (real-time) PCR
One to two thousand HSCs or unfractionated bone marrow cells were sorted into trizol and RNA was isolated using an RNeazy Mini Kit (Qiagen Sciences, MD). cDNA was constructed with oligo dT primers and SuperScript II reverse transcriptase (Invitrogen).
Quantitative PCR was performed with cDNA from 200 cell equivalents using a SYBR Green Kit and a LightCycler 480 (Roche). Each sample was normalized to β-actin and amplification products were tested for specificity by melting curves, gel electrophoresis, and sequencing.
Quantitative PCR primers are listed in Supplemental 
Neurogenesis
Neurogenesis in the olfactory bulb was assessed as previously described 27 . Animals were injected intraperitoneally with 50mg 5-bromo-deoxyuridine (BrdU)/kg body mass (Sigma, St. Louis, MO), and then given 1mg/ml BrdU in their drinking water for 8 days. 
Isolation of CNS progenitor cells
Subventricular zone cells were isolated by microdissection in Opti-MEM and digested for 20 minutes at 37°C in 0.025%Trypsin/0.5mM EDTA (Calbiochem) and 200U/mL DNase1 (Sigma). Enzymatic digestion was stopped by washing cells in L15 medium with 1mg/ml BSA (Sigma), 10mM HEPES pH7.4 (Bio Whittaker), 1% penicillin/streptomycin, and 200U/ml DNase1. Cells were passed though a 45μm nylon screen, counted, and plated.
CNS cell culture and self-renewal
Cells were plated at clonal density (0.67cells/μl) in CNS "self-renewal medium": a 5:3 mixture of DMEM-low glucose:Neurobasal medium supplemented with 10% chick embryo extract 28 , 1% N2 supplement, 2% B27 supplement, 1% penicillin/ streptomycin, 50μM β-mercaptoethanol (Sigma), 20ng/ml human bFGF (R&D Systems) and 20 ng/ml EGF (R&D Systems). Neurospheres were evaluated for size, and frequency after 8-10 days of culture. To assess self-renewal potential, individual 8-9 day old primary neurospheres were triturated to yield single cell suspensions, then subcloned to secondary cultures and grown for 5-8 days in self-renewal medium. Self-renewal was expressed as the number of secondary neurospheres generated per primary neurosphere. Multipotency was assessed by allowing neurospheres to differentiate in adherent cultures on fibronectin (Biomedical Technologies INC., Sloughton, MA) coated plates in "differentiation medium" that was similar to self-renewal medium except that it contained 0.5% fetal bovine serum (Gibco), lacked chick embryo extract, EGF, and had only 10ng/ml bFGF. Cells were fixed after 5-8 days in culture and stained for oligodendrocytes (O4), neurons (TuJ1, Covance) and astrocytes (GFAP, Sigma).
Isolation of PNS progenitor cells
The outer muscle/plexus layers of the gut were dissected from the exterior surface of the gut wall in Hank's buffered saline solution (HBSS -) without calcium or magnesium. Single cell suspensions were generated by digestion in 1mg/ml Collagenase type IV (Worthington, Lakewood, NJ) in HBSS -for 30 minutes at 37°C followed by a 10 minute digestion at 37°C in 10U papain (Worthington). Enzymatic digestion was quenched by washing cells with L15 medium with 1mg/ml BSA, 10mM HEPES pH7.4, 1% penicillin/streptomycin, and 200U/ml DNase1. Cells were passed though a 45μm nylon screen, counted, and plated.
PNS cell culture and self-renewal assay
Cells were plated at clonal density (0.67cells/μl) in PNS self-renewal medium: a 5:3 mixture of DMEM-low glucose:Neurobasal medium supplemented with 15% chick embryo extract, 1% N2 supplement, 2% B27 supplement, 1% penicillin/streptomycin, 50μM β-mercaptoethanol, 35mg/ml retinoic acid, 20ng/ml human bFGF (R&D Systems), and 20 ng/ml IGF1 (R&D Systems). Neurospheres were evaluated for size and frequency after 9-12 days of culture. To assess self-renewal potential, individual 9-10 day old primary neurospheres were replated on fibronectin-coated plates and cultured adherently for three days, followed by trypsin/EDTA digestion and trituration to yield single cell suspensions. The cells from individual neurospheres were then subcloned to secondary cultures and grown for 5-8 days in selfrenewal medium. Self-renewal was expressed as the number of secondary neurospheres generated per primary neurosphere. Multipotency was assessed by allowing neurospheres to differentiate in adherent cultures on fibronectin-coated plates in PNS differentiation medium that was similar to self-renewal medium except that it contained 0.5% fetal bovine serum, and lacked chick embryo extract, IFG1, and had only 10ng/mL bFGF. Cells were fixed after 5-8 days in culture and stained for smooth muscle (smooth muscle actin, Sigma), neurons (peripherin, Chemicon) and astrocytes (GFAP, Sigma).
RESULTS
Aldh1a1 expression increases with age in HSCs
We reanalyzed previously published gene expression profile data from Thy1.1 low Sca- (Fig. 1B) .
To test whether Aldh1a1 regulates HSC function we analyzed Aldh1a1 deficient mice 23 .
To confirm these mice carried the targeted allele we performed quantitative (real-time) RT-PCR using four sets of primers that spanned the Aldh1a1 transcript: primer set A was 5' of exon 11, primer set B was in exons 11 and 12, primer set C spanned from exon 10 to 12, and primer set D was 3' of exon 11 (see Fig. 1C for a description of primer binding sites). Primer set B amplified the predicted product from heterozygous mice but nothing from Aldh1a1 deficient mice, confirming they carried the targeted allele ( Fig. 1D-E) . Primer sets A and D amplified the predicted products, but Aldh1a1 deficient mice had template levels for these products that were 3 to 8 fold lower than in heterozygous controls. Primer set C amplified the expected products from Aldh1a1 deficient and heterozygous controls: the mutant amplicon was shortened by the lack of exon 11, carried the frameshift mutation that reflected gene targeting, and was present at 18-fold lower levels than wild-type ( Fig. 1D-E 1D) and HSCs (Fig. 1E ) of Aldh1a1 deficient mice and littermate controls. Aldh1a7 was the only family member that showed significantly altered expression within Aldh1a1 deficient mice, and its expression was two to three-fold reduced in HSCs and bone marrow cells from in Aldh1a1 deficient mice ( Fig. 1D-E 
Aldefluor staining does not distinguish mouse HSCs and is not determined by Aldh1a1
To test whether Aldefluor staining reflects Aldh1a1 activity in hematopoietic cells we compared the Aldefluor staining of bone marrow and HSCs from wild-type and Aldh1a1- (Fig. 2A,B) was unaffected by Aldh1a1-deficiency in both young adult and old adult mice (Fig. 2B, C Nonetheless, they do not rule out the possibility that Aldefluor staining may be used to enrich
HSCs when combined with lineage depletion and additional fractionation steps 13, 14 .
Aldh1a1 is dispensable for normal hematopoiesis
Since Aldh1a1 was strongly expressed by HSCs (Fig. 1 ) and has been suggested to
regulate HSC function, we tested whether Aldh1a1 was required for normal hematopoiesis.
Wild-type and Aldh1a1 +/-mice were indistinguishable and were therefore used interchangeably as littermate controls. We did not detect any difference in the bone marrow or spleen of Aldh1a1-deficient as compared to littermate control mice in terms of cellularity (Fig. 3A) ,
CD150
+ CD41 -CD48 -Sca1 + c-kit + HSC frequency (Fig. 3A) , colony-forming progenitor frequency (Fig. 3B ), or composition with respect to the frequency of B, T, erythroid, and myeloid lineage cells (Fig. 3C ). These data suggest Aldh1a1 is not required for steady-state hematopoiesis in young adult mice.
Since Aldh1a1 expression increases with age in HSCs (Fig. 1B) , we examined whether Aldh1a1 becomes a critical regulator of hematopoiesis in old mice. To test this we aged
Aldh1a1-deficient and littermate control mice and analyzed them between 21 and 27 months of age. However, we still observed no effect of Aldh1a1 deficiency on cellularity (Fig. 3A) ,
+ c-kit + HSC frequency (Fig. 3A) , colony-forming progenitor frequency (Fig. 3B ), or lineage composition (Fig. 3C ) of the bone marrow or spleen. These data indicate that although Aldh1a1 expression increases dramatically with age in HSCs, Aldh1a1 remains dispensable for normal hematopoiesis in old mice.
Aldh1a1 is dispensable for normal HSC function
To test whether Aldh1a1 is required for normal HSC function we performed competitive reconstitution assays using whole bone marrow cells from 2 month old, 1 year old, and 2 year old Aldh1a1-deficient and littermate control mice. In each case, 300,000 donor (CD45. 
Aldh1a1
-/-and control cells (Fig. 4) 
Aldh1a1 non-cell-autonomously regulates the cyclophosphamide sensitivity of HSCs
HSC mobilization in response to G-CSF treatment involves an expansion in HSCs followed by migration from the bone marrow to the spleen 25, 32 . To test whether these processes are regulated by Aldh1a1 we administered G-CSF on 4 consecutive days to Aldh1a1-deficient mice and littermate controls. Aldh1a1 deficiency did not significantly affect bone marrow cellularity, spleen cellularity, or total CD150 + CD41 -CD48 -Sca1 + c-kit + HSC numbers in the bone marrow or spleen (Fig. 5A ). These data demonstrate that HSCs do not require Aldh1a1 to expand in number or to mobilize in response to G-CSF.
An alternative method of mobilization involves cyclophosphamide treatment, followed by daily injections of G-CSF 25 . Aldh1a1 is known to detoxify cyclophosphamide by metabolizing the biologically active derivative, a process that at least partially occurs in the liver 5, 6, 33 To assess whether the increased sensitivity of Aldh1a1-deficient HSCs to cyclophosphamide reflects a specific role for Aldh1a1 in the metabolism of cyclophosphamide, or a more general role in the response to myeloablative compounds, we also tested the sensitivity of Aldh1a1-deficient mice to weekly injections of 5-fluorouracil. 5-fluorouracil is not thought to be metabolized by ALDHs. The survival of Aldh1a1-deficient mice was not significantly different as compared to littermate controls in response to weekly 5-fluoruracil administration (Fig. 5D ). This suggests that Aldh1a1 is required for the metabolism of cyclophosphamide, not for a general protective effect against myeloablative or proliferationinducing compounds.
Aldh1a1 is dispensable for central nervous system (CNS) stem cell function
Aldh1a1 is expressed by CNS stem cells 22 and Aldefluor has been used to isolate these stem cells 17 . To test whether Aldh1a1 regulates CNS stem cell function, we dissociated lateral ventricle subventricular zone (SVZ) cells from young and old adult mice and cultured them at clonal density (1 cell/1.5 μl) for 8-9 days 34 . Aldh1a1 deficiency did not significantly affect the percentage of SVZ cells that formed neurospheres (Fig. 6A) , the diameter of these neurospheres (Fig. 6B) , or their ability to undergo multilineage differentiation (Fig. 6C, D) .
Aldh1a1 deficiency also did not significantly affect the ability of primary neurospheres to form secondary neurospheres upon subcloning (Fig. 6E) or the size of these secondary neurospheres (Fig. 6F) . These data suggest Aldh1a1 deficiency does not affect CNS stem cell frequency or function in young or old adult mice.
SVZ stem cells undergo neurogenesis throughout adult life, forming interneurons that migrate into the olfactory bulb 27 . To test whether Aldh1a1 deficiency affects the rate of neurogenesis in vivo we administered 5-bromo-deoxyuridine (BrdU) to 18 month-old Aldh1a1-deficient and littermate control mice for 8 days to mark dividing SVZ progenitors, followed by one month without BrdU to allow these cells to migrate into the olfactory bulb and differentiate into neurons 27 . Then we sacrificed the mice, cut sagittal sections through the olfactory bulb, and stained with antibodies against BrdU and NeuN (a mature neuronal marker). Aldh1a1 deficiency did not affect the frequency of BrdU + NeuN + neurons observed in sections (Fig. 6G, H) . This indicates that Aldh1a1 is not required for normal CNS stem cell function or neurogenesis in vivo.
Aldh1a1 is dispensable for peripheral nervous system stem cell function
Aldh1a1 is also expressed by the neural crest stem cells (NCSCs) that give rise to the enteric nervous system during fetal development 35 and that persist throughout adult life in the gut wall 36 . qPCR analysis of Aldh1a1 expression levels of flow-cytometrically isolated p75+ gut NCSCs [36] [37] [38] revealed that Aldh1a1 expression levels increase with age in NCSCs in a manner similar to that observed in HSCs: Aldh1a1 expression levels increased 2.4-fold from embryonic day 14 to postnatal day 15 and 144-fold from postnatal day 15 to 2 years (data not shown). To test whether Aldh1a1 regulates NCSC function, we cultured dissociated cells from the outer plexus/muscle layers of the gut from young and old adult Aldh1a1-deficient and littermate control mice according to protocols that we developed previously to study adult NCSC function 34, 39 . Aldh1a1 deficiency had no effect on the percentage of gut cells that formed neurospheres in culture (Fig. 7A ), neurosphere diameter (Fig. 7B) , the differentiation of these neurospheres (Fig. 7C, D) , or the ability of neurospheres to give rise to secondary neurospheres upon subcloning (Fig. 7E) . These data suggest that Aldh1a1 deficiency does not affect gut NCSC frequency or function in young or old adult mice.
DISCUSSION
In agreement with prior studies 18, 19, 22 , we found that Aldh1a1 is preferentially expressed by HSCs as compared to other hematopoietic cells, particularly in old mice (Fig. 1) . We also observe increasing Aldh1a1 expression in neural stem cells with age (data not shown).
However, our data demonstrate that Aldh1a1 is not an important regulator of stem cell function in the hematopoietic and nervous systems. Aldh1a1 deficiency did not affect hematopoiesis, HSC maintenance, or HSC function in either young or old adult mice (Fig. 3-4) . Aldh1a1 deficiency also did not affect CNS stem cell frequency, function, or olfactory bulb neurogenesis (Fig. 6) . Finally, Aldh1a1 deficiency did not affect the frequency or function of gut NCSCs (Fig.   7) . Moreover, the fact that Aldh1a1-deficient mice are developmentally normal, fertile, and have a normal lifespan 23 suggests that there are also no gross defects in stem cell function in other tissues. Although Aldh1a1 tends to be expressed at higher levels in stem cells as compared to other cells in the hematopoietic and nervous systems (Fig. 1 ) 18, 19, 22 , it is not a critical regulator of adult stem cell function in mice.
There is good reason to believe that Aldh1a1 deficient mice have a complete loss of Aldh1a1 function. The targeted exon contains a domain required for substrate binding and tetramerization, both of which are necessary for all known Aldh1a1 functions 23 . Splicing around the targeted exon results in a frameshift. These mice lack the expression of all detectable Aldh1a1 protein by Western blot using a polyclonal antiserum and exhibit reduced retinoic acid synthesis 23, 24 . Consistent with this, our data suggest that the mutant mRNA is destabilized ( We were unable to distinguish mouse HSCs from other hematopoietic cells based on Aldefluor staining. HSCs were similar to most other bone marrow cells in the degree to which they stained with Aldefluor (Fig. 2) . This observation agrees with the results from another recent study 12 . It remains possible that Aldefluor staining can help to enrich HSCs when combined with other criteria, such as lineage depletion 13, 14 , but Aldefluor staining on its own is not an effective marker of mouse HSCs. Thus, while high levels of Aldefluor staining enrich human hematopoietic and breast epithelial stem cells 11, 15, 16 , strong Aldefluor staining is not a general stem cell marker.
Although Aldefluor staining has often been assumed to reflect Aldh1a1 activity, Aldh1a1 deficiency did not affect Aldefluor staining of mouse HSCs or bone marrow cells (Fig. 2B ). This suggests that most ALDH activity in mouse hematopoietic cells derives from other ALDHs, despite the prominent expression of Aldh1a1. We also observed clear expression of Aldh2, Aldh3a2, and Aldh9a1 in HSCs and other hematopoietic cells (Fig. 1) , raising the possibility that one or more of these ALDHs could be responsible for Aldefluor staining. ALDH activity may also be conferred by different enzymes in mouse and human stem cells.
Although Aldh1a1 did not regulate stem cell function in any discernible way under physiological conditions, it was non-cell-autonomously required to detoxify cyclophosphamide.
Aldh1a1-deficient mice exhibited significantly lower numbers of HSCs in the spleen after cyclophosphamide/G-CSF treatment, but Aldh1a1-deficient HSCs were not at a competitive disadvantage to control HSCs when transplanted into wild-type mice and treated with cyclophosphamide ( Fig. 5) . These results are consistent with a known role for Aldh1a1 in the liver in the metabolism of the active derivative of cyclophosphamide [4] [5] [6] [7] .
Our study represents the first direct test of Aldh1a1 function in stem cells. We detected Similar results were obtained using c-kit + Flk-2 -Lineage -Sca1 + HSCs (Suppl. Fig. 1 ). For personal use only. on April 14, 2017. by guest www.bloodjournal.org From
